SCHEMBL5465480

SCHEMBL5465480

CCOc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ncccc3C#N)CC2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.63
MEN1 O00255 3/20 0.63
P2RY1 P47900 4/20 0.47
PANK3 Q9H999 1/20 0.47
NPC1 O15118 4/20 0.47
LMNA P02545 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 3/20 0.46
RAB9A P51151 2/20 0.46
CASP3 P42574 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
POLB P06746 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453434 0.88 KMT2A (0.48) KMT2AMEN1P2RY1PANK3NPC1
SCHEMBL5459054 0.88 MEN1 (0.48) KMT2AMEN1P2RY1PANK3NPC1
SCHEMBL5464810 0.87 KMT2A (0.54) KMT2AMEN1P2RY1NPC1LMNA
SCHEMBL5454288 0.87 MEN1 (0.49) KMT2AMEN1PANK3NPC1LMNA
SCHEMBL5466982 0.86 MAPT (0.47) KMT2AMEN1P2RY1PANK3NPC1
SCHEMBL5467032 0.84 PANK3 (0.46) KMT2AMEN1P2RY1PANK3NPC1
SCHEMBL5454308 0.83 NAMPT (0.50) KMT2AMEN1PANK3NPC1LMNA
SCHEMBL5459962 0.83 PANK3 (0.47) KMT2AMEN1P2RY1PANK3NPC1
SCHEMBL5465242 0.82 MEN1 (0.52) KMT2AMEN1PANK3ALDH1A1MAPT
SCHEMBL5458442 0.82 MAPT (0.47) KMT2AMEN1PANK3NPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 KMT2A 1350/4885MEN1 1828/4885P2RY1 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.